financing

News

Ambros' $125m for pain disorder drug, and other financings

Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.

News

SanegeneBio raises $110m for RNAi, plus other financings

Biotech financings this week include SanegeneBio's Lilly-backed $110m Series B, with Sidera, D3 Bio, BlossomHill, and Prolynx also raising new funds.

News

Protego's $130m for amyloidosis drug, and other financings

Our latest crop of biotech financings has nine-figure rounds for Protego and Triana, with Excelsior Sciences and SciNeuro also raising new funds.

News

ADC specialist Solve raises $120m, and other biofinancings

Our round-up of biofinancings is led by a $120m round for ADC specialist Solve, with Aspen, Artios, Profluent, and Gate Bioscience also raising funds.

News

Sofinnova Partners raises €650m for early-stage biotechs

European life sciences venture capital company Sofinnova Partners has closed its latest fund, Sofinnova Capital XI, raising €650 million.

News

Braveheart, AAVantgarde rounds head recent biofinancings

Our latest crop of biotech financings has nine-figure rounds for Braveheart and AAVantgarde, with Azalea Therapeutics and NEOK Bio also raising funds.

Ambros' $125m for pain disorder drug, and other financings

SanegeneBio raises $110m for RNAi, plus other financings

Protego's $130m for amyloidosis drug, and other financings

ADC specialist Solve raises $120m, and other biofinancings

Sofinnova Partners raises €650m for early-stage biotechs

Braveheart, AAVantgarde rounds head recent biofinancings

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

financing

Editor's Picks